JAN 05, 2021 9:30 AM PST

Synthetic Psychedelic Treats Depression Without Hallucinations

WRITTEN BY: Annie Lennon

Psychedelics are receiving an increasing amount of attention- both in research and in the media- for their potential to treat mental health conditions from addiction to anxiety and depression. Now, researchers from the University of California have synthesized a non-hallucinogenic drug that may be effective in combatting these conditions. 

The researchers derived their compound from ibogaine, a psychedelic compound from Tabernanthe iboga, a rainforest shrub native to West Africa. Using a drug-designing method known as function-oriented synthesis, they were able to identify core aspects of how ibogaine works to recreate in a synthetic molecule called tabernanthalog (TBG). 

So far, the researchers have conducted several tests on animals using the substance. From experiments with zebrafish, for example, they found that TBG has a lower toxicity level than ibogaine itself. But the results don't stop there. 

They also found that a single dose of the substance has long-lasting anti-addictive effects on mice addicted to alcohol and rats addicted to heroin. Further studies with mice have shown that the drug has similar antidepressant effects in mice as ketamine, providing both fast-acting and effective relief. 

In the midst of this, they also found that when on the drug, mice don't twitch their heads in a way that indicates they are hallucinating. This is an important factor as hallucinations can be a major cause of anxiety for patients taking psychedelic treatments, and thus mean that they require significant oversight.

The drug also seems to promote neuronal growth. A day after rats were treated with TBG, researchers observed that their brain cells developed more dendritic spines, or 'branches'. How this translates to changes in behavior, however, is yet to be established. 

While the drug is still in the early stages of development, results so far are indicative of a promising, fast-acting alternative to conventional mental health treatments. Given the overlap of many psychiatric conditions, the researchers are optimistic that TBG may develop into a treatment for multiple conditions one day. 

 

Sources: Science AlertNatureMedical News Today

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
DEC 01, 2020
Neuroscience
Shorter Reinforcement Delays Make Neurofeedback More Effective
DEC 01, 2020
Shorter Reinforcement Delays Make Neurofeedback More Effective
Researchers at Russia's Higher School of Economics (HSE) have found that reducing delay in neurofeedback (NFB) signi ...
DEC 28, 2020
Neuroscience
Prenatal Metal Exposure Has Long Term Health Consequences
DEC 28, 2020
Prenatal Metal Exposure Has Long Term Health Consequences
Researchers from Rutgers University have found that prenatal exposure to metals, including lead, arsenic, cobalt, and ni ...
FEB 11, 2021
Neuroscience
Messenger Substances in Brain Affect Strategic Decision Making
FEB 11, 2021
Messenger Substances in Brain Affect Strategic Decision Making
A team of psychologists and physicists from Germany have found that variations in two messenger substances in the brain ...
FEB 20, 2021
Neuroscience
Brain Activity Predicts Onset of PTSD
FEB 20, 2021
Brain Activity Predicts Onset of PTSD
Why is it that some people develop symptoms of post-traumatic stress disorder (PTSD) after a stressful event, while othe ...
FEB 20, 2021
Drug Discovery & Development
Deep Brain Stimulation Offsets Epileptic Seizures
FEB 20, 2021
Deep Brain Stimulation Offsets Epileptic Seizures
Researchers from the University of Freiburg in Germany have found that deep brain stimulation (DBS) in the brain’s ...
MAR 08, 2021
Genetics & Genomics
A Slowdown in Cells' Protein Construction Drives Huntington's
MAR 08, 2021
A Slowdown in Cells' Protein Construction Drives Huntington's
Huntington's disease begins with symptoms like movement and balance problems, weakness, and behavioral disturbances, and ...
Loading Comments...